The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, open-label, neoadjuvant, randomized study of LCL161 with paclitaxel in patients with triple-negative breast cancer (TNBC).
 
Marina Parton
Honoraria - Eisai
Consulting or Advisory Role - Amgen; AstraZeneca
Speakers' Bureau - Eisai; Roche Pharma AG
Travel, Accommodations, Expenses - Amgen; Novartis; Roche Pharma AG
 
Aditya Bardia
No Relationships to Disclose
 
Sherko Kummel
Honoraria - Celgene; Novartis; Roche Pharma AG
Consulting or Advisory Role - Roche Pharma AG
Travel, Accommodations, Expenses - Celgene; Roche Pharma AG
 
Laura G Estevez
No Relationships to Disclose
 
Chiun-Sheng Huang
Honoraria - Novartis; Roche Pharma AG
Research Funding - AstraZeneca (Inst); Biomira (Inst); Boehringer Ingelheim (Inst); Lilly (Inst); Novartis (Inst); OBI Pharma (Inst); Roche Pharma AG (Inst)
 
Javier Cortes Castan
Honoraria - Celgene; Eisai; Novartis; Roche Pharma AG
Consulting or Advisory Role - Celgene; Roche Pharma AG
 
Manuel Ruiz Borrego
No Relationships to Disclose
 
Melinda L. Telli
Consulting or Advisory Role - OncoPlex Diagnostics; Vertex
Research Funding - Abbvie; Biomarin; Calithera Biosciences; Novartis; PharmaMar; Sanofi
 
Ana Lluch
Speakers' Bureau - Novartis; Pfizer; Roche Pharma AG
 
Rafael Lopez
Speakers' Bureau - Novartis; Roche Pharma AG
 
J. Thaddeus Beck
Consulting or Advisory Role - Novartis
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Genentech (Inst); Lilly (Inst); Novartis (Inst)
 
Roohi Ismail-Khan
Speakers' Bureau - Amgen
 
Shin-Cheh Chen
No Relationships to Disclose
 
Sara A. Hurvitz
Honoraria - Genentech/Roche
Research Funding - Amgen (Inst); Boehringer Ingelheim (Inst); Dignitana (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Novartis (Inst); OBI Pharma (Inst); Pfizer (Inst); Puma Biotechnology (Inst); sanofi (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Genentech/Roche; Lilly; Novartis; Pfizer
 
Ingrid A. Mayer
Consulting or Advisory Role - Genentech/Roche; Novartis
Research Funding - Novartis
 
Rolando S. Atienza
Employment - Novartis
 
Scott Cameron
Employment - Novartis
Leadership - Novartis
Stock and Other Ownership Interests - Novartis
Patents, Royalties, Other Intellectual Property - Patent relating to IAP biology
Travel, Accommodations, Expenses - Novartis
 
Mizue Krygowski
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Sung-Bae Kim
Research Funding - Novartis